Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK

Oncogene

Volumn 23, Issue 42, 2004, Pages 7053-7066

  Pettersson, Filippa ^a   Couture, Marie Claude ^a   Hanna, Nessrine ^a   Miller Jr , Wilson H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; ER negative breast cancer; MAPK; Protein kinase C inhibitors; Retinoids

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; BEXAROTENE; CASPASE 3; DNA FRAGMENT; ESTROGEN RECEPTOR; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C INHIBITOR; RETINOIC ACID; RETINOID; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN MDA MB 231; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HUMANS; INDOLES; MALEIMIDES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; RETINOIDS;

EID: 4844224727     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207956     Document Type: Article

References (102)

1. Adachi S, Okuno M, Matsushima-Nishiwaki R, Takano Y, Kojiraa S, Friedman SL, Moriwaki H and Okano Y. (2002). Hepatology, 35, 332-340.
2. Adan Y, Goldman Y, Haimovitz R, Mammon K, Eilon T, Tal S, Tene A, Karmel Y and Shinitzky M. (2003). Cancer Lett., 194, 67-79.
3. Appierto V, Villani MG, Cavadini E, Lotan R, Vinson C and Formelli F. (2004). Cell Death Differ., 11, 270-279.
4. Basu A, Mohanty S and Sun B. (2001). Biochem. Biophys. Res. Commun., 280, 883-891.
5. Boskovic G, Desai D and Niles RM. (2002). J. Biol. Chem., 277, 2611-2619.
6. Bost F, Caron L, Marchetti I, Dani C, Le Marchand-Brustel Y and Binetruy B. (2002). Biochem. J., 361, 621-627.
7. Brodie C and Blumberg PM. (2003). Apoptosis, 8, 19-27.
8. Busby EC, Leistritz DF, Abraham RT, Karnitz LM and Sarkaria JN. (2000). Cancer Res., 60, 2108-2112.
9. Cho Y and Talmage DA. (2001). Exp. Cell Res., 269, 97-108.
10. Cho Y, Tighe AP and Talmage DA. (1997). J. Cell Physiol., 172, 306-313.
11. Clark AS, West KA, Blumberg PM and Dennis PA. (2003). Cancer Res., 63, 780-786.
12. Crowe DL, Kim R and Chandraratna RA. (2003). Mol. Cancer Res., 1, 532-540.
13. Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC and Pierotti MA. (1995). Blood, 85, 359-367.
14. Delmotte M-H, Tahayato A, Formstecher P and Lefebvre P. (1999). J. Biol. Chem., 274, 38225-38231.
15. Denning MF, Wang Y, Nickoloff BJ and Wrone-Smith T. (1998). J. Biol. Chem., 273, 29995-30002.
16. del Rincon SV, Rousseau C, Samanta R and Miller Jr WH. (2003). Oncogene, 22, 3353-3360.
17. De Luca LM, Darwiche N, Jones CS and Scita G. (1995). Sci. Am. - Sci. Med., 2, 28-37.
18. Drew L, Kumar R, Bandyopadhyay D and Gupta S. (1998). Int. Immunol., 10, 877-889.
19. Evans RM. (1988). Science, 240, 889-895.
20. Fitzgerald P, Teng M, Chandraratna RAS, Heyman RA and Allegretto EA. (1997). Cancer Res., 57, 2642-2650.
21. Gauthier ML, Torretto C, Ly J, Francescutti V and O'Day DH. (2003). Biochem. Biophys. Res. Commun., 307, 839-846.
22. Giannini G, Dawson MI, Zhang X and Thiele CJ. (1997). J. Biol. Chem., 272, 26693-26701.
23. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM and Piwnica-Worms H. (2000). J. Biol. Chem., 275, 5600-5605.
24. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ and Johannes FJ. (1996). FEBS Lett., 392, 77-80.
25. Gschwend JE, Fair WR and Powell CT. (2000). Mol Pharmacol., 57, 1224-1234.
26. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G and Marks F. (1994). Biochem. Biophys. Res. Commun., 199, 93-98.
27. Hail Jr N, Youssef EM and Lotan R. (2001). Cancer Res., 61, 6698-6702.
28. Hofmann J. (2001). Rev. Physiol. Biochem. Pharmacol., 142, 1-96.
29. Hsu SL, Hsu JW, Liu MC, Chen LY and Chang CD. (2000). Exp. Cell Res., 258, 322-331.
30. Huigsloot M, Tijdens RB and van de Water B. (2003). Mol. Pharmacol., 64, 965-973.
31. Irie N, Sakai N, Ueyama T, Kajimoto T, Shirai Y and Saito N. (2002). Biochem. Biophys. Res. Commun., 298, 738-743.
32. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E and Fisher PB. (1994). Oncogene, 9, 3397-3406.
33. Johnson GL and Lapadat R. (2002). Science, 298, 1911-1912.
34. Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb DK, Parmar S, Giafis N, Kalvakolanu DV, Rahman A, Uddin S, Minucci S, Tallman MS, Fish EN and Platanias LC. (2003). J. Biol. Chem., 278, 32544-32551.
35. Kawakami K, Futami H, Takahara J and Yamaguchi K. (1996). Biochem. Biophys. Res. Commun., 219, 778-783.
36. Keranen LM, Dutil EM and Newton AC. (1995). Curr. Biol., 5, 1394-1403.
37. Kitareewan S, Spinella MJ, Allopenna J, Reczek PR and Dmitrovsky E. (1999). Oncogene, 18, 5747-5755.
38. Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M and Koeffler HP. (1996). Blood, 87, 1977-1984.
39. Lee H-J, Suh Y-A, Robinson MJ, Clifford JL, Hong WK, Woodgett JR, Cobbs MH, Mangelsdorf DJ and Kurie JM. (2000a). J. Biol. Chem., 275, 32193-32199.
40. Lee HW, Smith L, Pettit GR, Vinitsky A and Smith JB. (1996). J. Biol. Chem., 271, 20973-20976.
41. Lee MO, Han SY, Jiang S, Park JH and Kim SJ. (2000b). Biochem. Pharmacol., 59, 485-496.
42. Lee YJ, Soh JW, Jeoung DI, Cho CK, Jhon GJ, Lee SJ and Lee YS. (2003). Biochim. Biophys. Acta, 1593, 219-229.
43. Le XF, Marcelli M, McWatters A, Nan B, Mills GB, O'Brian CA and Bast Jr RC. (2001). Oncogene, 20, 8258-8269.
44. Le XF, McWatters A, Wiener J, Wu JY, Mills GB and Bast Jr RC. (2000). Clin. Cancer Res., 6, 260-270.
45. Li D, Zimmerman TL, Thevananther S, Lee HY, Kurie JM and Karpen SJ. (2002). J. Biol. Chem., 277, 31416-31422.
46. Li L, Lorenzo PS, Bogi K, Blumberg PM and Yuspa SH. (1999). Mol. Cell. Biol., 19, 8547-8558.
47. Lin HY, Shih A, Davis FB, Tang HY, Martine LJ, Bennett JA and Davis PJ. (2002). J. Urol., 168, 748-755.
48. Lippman SC, Heyman RA, Kurie JM, Benner SE and Hong WK. (1995). J. Cell Biochem., (Suppl 22), 1-10.
49. Liu Y LM, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC and Zhang X. (1996). Mol. Cell. Biol., 16, 1138-1149.
50. Lotan R. (1996). FASEB J., 10, 1031-1039.
51. Lu Z, Liu D, Hornia A, Devonish W, Pagano M and Foster DA. (1998). Mol. Cell. Biol., 18, 839-845.
52. Mandil R, Ashkenazi E, Blass M, Kronfeld I, Kazimirsky G, Rosenthal G, Umansky F, Lorenzo PS, Blumberg PM and Brodie C. (2001). Cancer Res., 61, 4612-4619.
53. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schuts G, Blumberg B, Kastner P, Mark M, Chambon P and Evans R. (1995). Cell, 83, 835-839.
54. Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES and Evans RM. (1991). Cell, 66, 555-561.
55. Mangiarotti R, Danova M and Alberici C. (1998). Br. J. Cancer, 77, 186-191.
56. Mann KK, Shao W and Miller Jr WH. (2001). Curr. Oncol. Rep., 3, 209-216.
57. Marchetti P, Zamzami N, Joseph B, Schraen-Maschke S, Méreau- Richard C, Costantini P, Métivier D, Susin SA, Kroemer G and Formstecher P. (1999). Cancer Res., 59, 6257-6266.
58. Martelli AM, Sang N, Borgatti P, Capitani S and Neri LM. (1999). J. Cell Biochem., 74, 499-521.
59. Matsushima-Nishiwaki R, Okuno M, Adachi S, Sano T, Akita K, Moriwaki H, Friedman SL and Kojima S. (2001). Cancer Res., 61, 7675-7682.
60. McCracken MA, Miraglia LJ, McKay RA and Strobl JS. (2003). Mol. Cancer Ther., 2, 273-281.
61. Mellor H and Parker PJ. (1998). Biochem. J., 332 (Part 2), 281-292.
62. Miller WH. (1998). Cancer, 83, 1471-1482.
63. Miranda MB, McGuire TF and Johnson DE. (2002). Leukemia, 16, 683-692.
64. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, Chandraratna RA and Davies PJ. (1995). Mol. Cell. Biol., 15, 3540-3551.
65. Ni H, Ergin M, Tibudan SS, Denning MF, Izban KF and Alkan S. (2003). Br. J. Haematol., 121, 849-856.
66. Ortiz MA, Lopez-Hernandez FJ, Bayon Y, Pfahl M and Piedrafita FJ. (2001). Cancer Res., 61, 8504-8512.
67. Parekh DB, Ziegler W and Parker PJ. (2000). EMBO J., 19, 496-503.
68. Pepper C, Ali K, Thomas A, Hoy T, Fegan C, Chowdary P, Kell J and Bentley P. (2002). Eur. J. Haematol., 69, 227-235.
69. Persons DL, Yazlovitskaya EM and Felling JC. (2000). J. Biol. Chem., 275, 35778-35785.
70. Pettersson F, Dalgleish AG, Bissonnette RP and Colston KW. (2002). Br. J. Cancer, 87, 555-561.
71. Platet N, Prevostel C, Derocq D, Joubert D, Rochefort H and Garcia M. (1998). Int. J. Cancer, 75, 750-756.
72. Radominska-Pandya A, Chen G, Czernik PJ, Little JM, Samokyszyn VM, Carter CA and Nowak G. (2000). J. Biol. Chem., 275, 22324-22330.
73. Rigobello MP, Scutari G, Friso A, Barzon E, Artusi S and Bindoli A. (1999). Biochem. Pharmacol., 58, 665-670.
74. Rochefort H, Glondu M, Sahla ME, Platet N and Garcia M. (2003). Endocr. Relat. Cancer, 10, 261-266.
75. Rosenauer A, Nervi C, Davison K, Lamph WW, Mader S and Miller Jr WH. (1998). Cancer Res., 58, 5110-5116.
76. Rousseau C, Pettersson F, Couture MC, Paquin A, Galipeau J, Mader S and Miller WH. (2003). J. Steroid Biochem. Mol. Biol., 86, 1-14.
77. Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J and Miller Jr WH. (1994). Cancer Res., 54, 6549-6556.
78. Sah JF, Eckert RL, Chandraratna RA and Rorke EA. (2002). J. Biol. Chem., 211, 9728-9735.
79. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH and Yue W. (2002). J. Steroid Biochem. Mol. Biol., 80, 239-256.
80. Sato S, Fujita N and Tsuruo T. (2002). Oncogene, 21, 1727-1738.
81. Sausville EA. (2003). Curr. Med. Chem. Anti-Cancer Agents, 3, 47-56.
82. Shao RG, Shimizu T and Pommier Y. (1997). Exp. Cell Res., 234, 388-397.
83. Sheikh MS, Shao ZM, Chen JC, Hussain A, Jetten AM and Fontana JA. (1993). J. Cell Biochem., 53, 394-404.
84. Sheikh MS, Shao ZM, Li XS, Dawson M, Jetten AM, Wu S, Conley BA, Garcia M, Rochefort H and Fontana JA. (1994). J. Biol. Chem., 269, 21440-21447.
85. She QB, Bode AM, Ma WY, Chen NY and Dong Z. (2001). Cancer Res., 61, 1604-1610.
86. Shih A, Davis FB, Lin HY and Davis PJ. (2002). J. Clin. Endocrinol. Metab., 87, 1223-1232.
87. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesh H, Kenney S and Boyd MR. (1990). J. Natl. Cancer Inst., 82, 1107-1112.
88. Solomon C, White JH and Kremer R. (1999). J. Clin. Invest., 103, 1729-1735.
89. Spanjaard RA, Ikeda M, Lee PJ, Charpentier B, Chin WW and Eberlein TJ. (1997). J. Biol. Chem., 272, 18990-18999.
90. Sun SY, Li W, Yue P, Lippman SM, Hong WK and Lotan R. (1999a). Cancer Res., 59, 2493-2498.
91. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK and Lotan R. (1999b). Oncogene, 18, 2357-2365.
92. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW and Ingram AJ. (2002). J. Biol. Chem., 211, 12710-12717.
93. Tenzer A, Zingg D, Rocha S, Hemmings B, Fabbro D, Glanzmann C, Schubiger PA, Bodis S and Pruschy M. (2001). Cancer Res., 61, 8203-8210.
94. Tillman DM, Izeradjene K, Szucs KS, Douglas L and Houghton JA. (2003). Cancer Res., 63, 5118-5125.
95. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E and Loriolle F. (1991). J. Biol. Chem., 266, 15771-15781.
96. van der Burg B, van der Leede BM, Kwakkenbos-Isbrucker L, Salverda S, de Laat SW and van der Saag PT. (1993). Mol. Cell. Endocrinol., 91, 149-157.
97. Wang X, Martindale JL and Holbrook NJ. (2000). J. Biol Chem., 275, 39435-39443.
98. Wu JM, DiPietrantonio AM and Hsieh TC. (2001). Apoptosis, 6, 377-388.
99. Yen A, Roberson MS, Varvayanis S and Lee AT. (1998). Cancer Res., 58, 3163-3172.
100. Yung BY and Hui EK. (1995). J. Biomed. Sci., 2, 154-159.
101. Zhao X, Demary K, Wong L, Vaziri C, McKenzie AB, Eberlein TJ and Spanjaard RA. (2001). Cell Death Differ., 8, 878-886.
102. Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S and De Luca LM. (1997). Exp. Cell Res., 234, 293-299.